as 11-07-2025 4:00pm EST
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | TARRYTOWN |
| Market Cap: | 3.3B | IPO Year: | 2005 |
| Target Price: | $86.40 | AVG Volume (30 days): | 410.8K |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 4.04 | EPS Growth: | -1.41 |
| 52 Week Low/High: | $59.51 - $90.04 | Next Earning Date: | 11-06-2025 |
| Revenue: | $1,110,479,000 | Revenue Growth: | -0.02% |
| Revenue Growth (this year): | -2% | Revenue Growth (next year): | 2.69% |
PBH Breaking Stock News: Dive into PBH Ticker-Specific Updates for Smart Investing
Zacks
4 days ago
MT Newswires
4 days ago
Zacks
4 days ago
Associated Press Finance
4 days ago
GlobeNewswire
4 days ago
Zacks
5 days ago
MT Newswires
20 days ago
Simply Wall St.
a month ago
The information presented on this page, "PBH Prestige Consumer Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.